{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T18:34:25Z","timestamp":1696876465781},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,7,30]],"date-time":"2009-07-30T00:00:00Z","timestamp":1248912000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s12028-009-9252-6","type":"journal-article","created":{"date-parts":[[2009,7,29]],"date-time":"2009-07-29T14:19:49Z","timestamp":1248877189000},"page":"317-321","source":"Crossref","is-referenced-by-count":15,"title":["Selective Immune Adsorption Treatment of Severe Guillain Barr\u00e9 Syndrome in the Intensive Care Unit"],"prefix":"10.1007","volume":"11","author":[{"given":"N.","family":"Galldiks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Dohmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Neveling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. R.","family":"Fink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. F.","family":"Haupt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,30]]},"reference":[{"key":"9252_CR1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(97)12308-X","volume":"352","author":"AF Hahn","year":"1998","unstructured":"Hahn AF. Guillain-Barre syndrome. Lancet. 1998;352:635\u201341.","journal-title":"Lancet"},{"key":"9252_CR2","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/mus.880160603","volume":"16","author":"K Arasaki","year":"1993","unstructured":"Arasaki K, Kusunoki S, Kudo N, Kanazawa I. Acute conduction block in vitro following exposure to antiganglioside sera. Muscle Nerve. 1993;16:587\u201393.","journal-title":"Muscle Nerve"},{"key":"9252_CR3","doi-asserted-by":"crossref","unstructured":"Efficiency of plasma exchange in Guillain-Barre syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barre syndrome. Ann Neurol. 1987;22:753\u201361.","DOI":"10.1002\/ana.410220612"},{"key":"9252_CR4","doi-asserted-by":"crossref","unstructured":"Plasmapheresis and acute Guillain-Barre syndrome. The Guillain-Barre syndrome Study Group. Neurology. 1985;35:1096\u2013104.","DOI":"10.1212\/WNL.35.8.1096"},{"key":"9252_CR5","unstructured":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome. Plasma Exchange\/Sandoglobulin Guillain-Barre Syndrome Trial Group. Lancet. 1997;349:225\u201330."},{"key":"9252_CR6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0022-510X(95)00357-8","volume":"137","author":"WF Haupt","year":"1996","unstructured":"Haupt WF, Rosenow F, van der Ven C, Borberg H, Pawlik G. Sequential treatment of Guillain-Barre syndrome with extracorporeal elimination and intravenous immunoglobulin. J Neurol Sci. 1996;137:145\u20139.","journal-title":"J Neurol Sci"},{"key":"9252_CR7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000050777","volume":"46","author":"HC Diener","year":"2001","unstructured":"Diener HC, Haupt WF, Kloss TM, et al. A preliminary, randomized, multicenter study comparing intravenous immunoglobulin, plasma exchange, and immune adsorption in Guillain-Barre syndrome. Eur Neurol. 2001;46:107\u20139.","journal-title":"Eur Neurol"},{"key":"9252_CR8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1526-0968.2004.00138.x","volume":"8","author":"S Okamiya","year":"2004","unstructured":"Okamiya S, Ogino M, Ogino Y, et al. Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barre syndrome. Ther Apher Dial. 2004;8:248\u201353.","journal-title":"Ther Apher Dial"},{"key":"9252_CR9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.clineuro.2004.12.019","volume":"107","author":"T Seta","year":"2005","unstructured":"Seta T, Nagayama H, Katsura K, et al. Factors influencing outcome in Guillain-Barre syndrome: comparison of plasma adsorption against other treatments. Clin Neurol Neurosurg. 2005;107:491\u20136.","journal-title":"Clin Neurol Neurosurg"},{"key":"9252_CR10","first-page":"372","volume":"61","author":"A Pencz","year":"1990","unstructured":"Pencz A, Garnier E. Immunoadsorption in the treatment of Guillain-Barre type polyradiculitis. Nervenarzt. 1990;61:372\u20135.","journal-title":"Nervenarzt"},{"key":"9252_CR11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0955-3886(93)90046-W","volume":"14","author":"C Jimenez","year":"1993","unstructured":"Jimenez C, Rosenow F, Grieb P, Haupt WF, Borberg H. Adsorption therapy with tryptophan-conjugated polyvinyl alcohol gels in 10 patients with acute Guillain-Barre syndrome. Transfus Sci. 1993;14:9\u201311.","journal-title":"Transfus Sci"},{"key":"9252_CR12","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/jnnp.57.5.578","volume":"57","author":"N Shibuya","year":"1994","unstructured":"Shibuya N, Sato T, Osame M, Takegami T, Doi S, Kawanami S. Immunoadsorption therapy for myasthenia gravis. J Neurol Neurosurg Psychiatry. 1994;57:578\u201381.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9252_CR13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1212\/WNL.45.2.338","volume":"45","author":"D Grob","year":"1995","unstructured":"Grob D, Simpson D, Mitsumoto H, et al. Treatment of myasthenia gravis by immunoadsorption of plasma. Neurology. 1995;45:338\u201344.","journal-title":"Neurology"},{"key":"9252_CR14","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","volume":"2","author":"RA Hughes","year":"1978","unstructured":"Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet. 1978;2:750\u20133.","journal-title":"Lancet"},{"key":"9252_CR15","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","volume":"326","author":"FG Meche van der","year":"1992","unstructured":"van der Meche FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. Dutch Guillain-Barre Study Group. N Engl J Med. 1992;326:1123\u20139.","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"9252_CR16","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","volume":"27","author":"AK Asbury","year":"1990","unstructured":"Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol. 1990;27(Suppl):S21\u20134.","journal-title":"Ann Neurol"},{"key":"9252_CR17","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.61.6.736","volume":"61","author":"RA Hughes","year":"2003","unstructured":"Hughes RA, Wijdicks EF, Barohn R, et al. Practice parameter: immunotherapy for Guillain-Barre syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2003;61:736\u201340.","journal-title":"Neurology"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-009-9252-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12028-009-9252-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-009-9252-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:06:48Z","timestamp":1559441208000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12028-009-9252-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,30]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["9252"],"URL":"https:\/\/doi.org\/10.1007\/s12028-009-9252-6","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,30]]}}}